- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sigma Pharmaceuticals Ltd (SIG)
Sigma Pharmaceuticals Ltd stock price live, this page displays ASX SIG stock exchange data. View the SIG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sigma Pharmaceuticals Ltd real time stock price chart below.
What Is the Sigma Pharmaceuticals Ltd Stock Price Today?
The Sigma Pharmaceuticals Ltd stock price today is 2.790.
What Is the Stock Symbol for Sigma Pharmaceuticals Ltd?
The stock symbol for Sigma Pharmaceuticals Ltd is "SIG."
What Stock Exchange Does Sigma Pharmaceuticals Ltd Trade On?
Sigma Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Sigma Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Sigma Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SIG quote. (ISIN: AU000000SIG5)
What Is the Sigma Pharmaceuticals Ltd Stock Price Today?
The Sigma Pharmaceuticals Ltd stock price today is 2.790.
What Is the Stock Symbol for Sigma Pharmaceuticals Ltd?
The stock symbol for Sigma Pharmaceuticals Ltd is "SIG."
What Stock Exchange Does Sigma Pharmaceuticals Ltd Trade On?
Sigma Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Sigma Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Sigma Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SIG quote. (ISIN: AU000000SIG5)
Sydney
Currency in AUD
2.790
+0.010(+0.36%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.760
2.800
52 wk Range
2.580
3.280
SIG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7602.800
52 wk Range
2.5803.280
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SIG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
3.800
Upside
+36.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.800
(+36.20% Upside)
Sigma Pharmaceuticals Ltd Earnings Call Summary for H1/2026
- Sigma Healthcare's H1 FY2026 revenue rose 14.9% to AUD 800M, driven by GLP-1 medicine sales and international expansion; stock surged 5.69%.
- Normalized EBIT increased 18.7% to AUD 582.9M; EPS grew 19.4% to AUD 0.034, reflecting strong operational efficiency and margin improvement.
- Chemist Warehouse network sales jumped 17.2%; international sales climbed 24.5% with continued expansion in New Zealand, Ireland, and Dubai markets.
- Company forecasts Q1 FY27 EPS of 1.3 USD and revenue of 1,559.1 USD, citing sustained GLP-1 demand and strategic store network growth.
- CEO Hooper highlighted GLP-1 rollout success; key risks include supply chain constraints, regulatory changes, and currency fluctuations impacting operations.
Last Updated: 2026-02-25, 07:30 p/m
Read Full TranscriptEarnings
Latest Release
Mar 20, 2025
EPS / Forecast
-0.01 / 1.46
Revenue / Forecast
3B / 2.33B
Compare SIG to Peers and Sector
Metrics to compare | SIG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSIGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 53.5x | 15.7x | −0.5x | |
PEG Ratio | - | 0.02 | 0.00 | |
Price/Book | 6.6x | 1.3x | 2.6x | |
Price / LTM Sales | 3.4x | 1.0x | 3.2x | |
Upside (Analyst Target) | 16.5% | 32.6% | 50.8% | |
Fair Value Upside | Unlock | 25.5% | 7.7% | Unlock |
As of February 4, 2025, Sigma Healthcare Limited was acquired by CW Group Holdings Limited, in a reverse merger transaction. Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. The company was founded in 1912 and is headquartered in Clayton, Australia.
People Also Watch
FAQ
What Is the Sigma Pharma (SIG) Stock Price Today?
The Sigma Pharma stock price today is 2.790 AUD.
What Stock Exchange Does Sigma Pharma Trade On?
Sigma Pharma is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Sigma Pharma?
The stock symbol for Sigma Pharma is "SIG."
What Is the Sigma Pharma Market Cap?
As of today, Sigma Pharma market cap is 4.390B AUD.
What Is Sigma Pharma's Earnings Per Share (TTM)?
The Sigma Pharma EPS (TTM) is -0.009.
From a Technical Analysis Perspective, Is SIG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sigma Pharma Stock Split?
Sigma Pharma has split 2 times.
What is the current trading status of Sigma Pharma (SIG)?
As of Apr 30, 2026, Sigma Pharma (SIG) is trading at a price of 2.790 AUD, with a previous close of 2.780 AUD. The stock has fluctuated within a day range of 2.760 AUD to 2.800 AUD, while its 52-week range spans from 2.580 AUD to 3.280 AUD.
What Is Sigma Pharma (SIG) Price Target According to Analysts?
The average 12-month price target for Sigma Pharma is 3.800 AUD, with a high estimate of 3.8 AUD and a low estimate of 3.8 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +36.20% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.